Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

BTK inhibitor

(… in-HIH-bih-ter)
A substance that blocks the activity of a protein called Bruton tyrosine kinase (BTK), which plays an important role in the development and maturation of B cells. B cells are a type of white blood cell that makes special proteins called antibodies. BTK inhibitors bind to the BTK protein, which is found on most B cells and some types of cancer cells. Blocking BTK may help keep cancer cells from growing. Some BTK inhibitors are used to treat cancer.
Search NCI's Dictionary of Cancer Terms